Properties of Uncommon Indirect Immunofluorescence Staining Patterns Determined during Antinuclear Antibody Detection on HEp-2 Cells. 2021

Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
Department of Laboratory Diagnostics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.

In this study, we aimed to assess the prevalence of uncommon staining patterns found during testing for the presence of antinuclear antibodies (ANA) and to determine their association with certain antibodies and clinical diagnoses. Presence of ANA and the staining pattern was determined in 10955 samples using indirect immunofluorescence (IIF) on HEp-2 cells. ANA-positive samples were assessed for presence of 14 specific antibody types using a microbead based system. Demographic data (age, sex) and clinical diagnoses were collected from the referral documentation. Particular staining patterns were then compared with a representative comparison group comprised of samples with common staining patterns using these criteria. There were 22 patterns present in less than 3% of samples each and these were jointly present in 42.43% of ANA-positive samples. Specific antibodies were found in proportions similar to the comparison group (46.06%) and varied significantly between patterns. Likewise, there were significant differences in antibody distribution in particular patterns. Some patterns were associated with presence of rheumatic diseases or inflammatory arthropathies, while in others there was a concurrent diagnosis of liver disease, or a neoplastic process. Many of the uncommon IIF patterns have distinctive characteristics that warrant further investigation in order to determine their role in diagnosing various diseases, not limited only to the illnesses of the rheumatic spectrum. IIF on HEp-2 cells remains an irreplaceable method because of the diversity of ANA, only a number of which can be detected using other standardised methods.

UI MeSH Term Description Entries

Related Publications

Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
January 2012, Clinical & developmental immunology,
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
September 2009, Annals of the New York Academy of Sciences,
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
June 2009, Deutsche medizinische Wochenschrift (1946),
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
January 2019, Methods in molecular biology (Clifton, N.J.),
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
June 2023, Clinical chemistry and laboratory medicine,
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
January 1984, Annales de biologie clinique,
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
February 2021, Auto- immunity highlights,
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
January 1987, Rinsho byori. The Japanese journal of clinical pathology,
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
June 2019, Annals of the rheumatic diseases,
Nada Tomić Sremec, and Ana Kozmar, and Josip Sremec, and Branimir Anić, and Drago Batinić
February 2017, Immunologic research,
Copied contents to your clipboard!